Anti-B7-H1/PD-L1/CD274 Antibody (Durvalumab)
Catalog No.
F1311
Anti-B7-H1/PD-L1/CD274 Antibody (Durvalumab)
Featured Products
Durvalumab (anti-PD-L1) is an IgG1κ monoclonal antibody that inhibits the interaction between PD-L1 and PD-1/CD80 (B7.1).
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- COA (Certificate Of Analysis)
- MSDS (Material Safety Data Sheet)
- Datasheet
146.32 kDa
Dry ice
1428935-60-7
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
C134, MEDI4736
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q9NZQ7
Human, Mouse, Cynomolgus
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human PD-L1 His at 2 ug/mL can bind Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (Durvalumab)
B7-H1 / PD-L1 / CD274
Please avoid freeze-thaw cycles.